External Defibrillators Market by Product Type and Geography - Global Opportunity Analysis and Industry Forecast, 2016-2023

  • ID: 4227017
  • Report
  • Region: Global
  • 170 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • Defibtech, Llc
  • GE Healthcare
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Physio-Control, Inc
  • Schiller Ag
  • MORE

External Defibrillators Market by Product Type [Manual External Defibrillator, Automated External Defibrillator (AED), and Wearable Cardioverter Defibrillator (WCD)] and Geography (North America, Europe, Asia-Pacific, and LAMEA) - Global Opportunity Analysis and Industry Forecast, 2016-2023

External defibrillators are light weight and portable devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. These devices form a vital tool to deliver a rapid response to the victims of cardiac arrest. Large scale demand for the installation of automated external defibrillators (AEDs) at public places to prevent fatal outcomes from SCA is the prime factor that drives the market growth.

The external defibrillator market was valued at $4,345 million in 2016, and is projected to reach $7,512 million by 2023, growing at a CAGR of 7.8% from 2017 to 2023. This is attributed to the growth in focus toward public access defibrillator (PAD) by the public & private organizations, along with the key players, which fuels the market growth. Other factors, such as rapid growth in geriatric population with elevated risk of targeted diseases, technological advancement for defibrillator devices, and increase in incidence of cardiovascular diseases drive the market growth. However, stringent regulations, increase in pricing pressure on players, and lack of awareness about sudden cardiac arrest (SCA) limit the market growth.

The global external defibrillators market is segmented on the basis of product type, end user, and geography. Based on product type, it is classified into manual external defibrillator, automated external defibrillator, and wearable external defibrillator. Automated external defibrillator is further bifurcated into semi-automated and fully automated defibrillators. Based on end user, it is categorized into hospitals, pre-hospitals, public access markets, alternative care market, and home. Geographically, the external defibrillator market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS

This report provides an extensive analysis of the current & emerging market trends and dynamics in the global external defibrillator market.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
This report entails the detailed quantitative analysis of the current trends and future estimations to identify the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
Region- and country-wise market conditions are analyzed in the report.

KEY MARKET SEGMENTS

By Product Type

Manual External Defibrillator
Automated External Defibrillator (AED)
Semi-Automated External Defibrillator
Fully Automated Defibrillator
Wearable Cardioverter Defibrillator (WCD)

By End User

Hospitals
Pre-Hospitals
Public Access Market
Alternate Care Market
Home

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Argentina
Egypt
Israel
South Africa
Rest of LAMEA
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Defibtech, Llc
  • GE Healthcare
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Physio-Control, Inc
  • Schiller Ag
  • MORE
CHAPTER 1. INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. KEY PLAYERS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2. EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3. MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.2.3. Market Share Analysis, 2016

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Growing incidence of cardiovascular diseases
3.3.1.2. Technological advancements
3.3.1.3. Rising awareness regarding public access defibrillators (PADs)
3.3.1.4. High presence of unmet medical needs especially in untapped economies

3.3.2. Restraints

3.3.2.1. Lack of awareness regarding sudden cardiac arrest (SCA) and device availability
3.3.2.2. Safety concerns related to automated external defibrillators
3.3.2.3. Limited insurance coverage and high cost of defibrillators

3.3.3. Opportunities

3.3.3.1. Lucrative opportunities in emerging economies
3.3.3.2. Favorable government initiatives for the adoption of AEDs at public places

CHAPTER 4. EXTERNAL DEFIBRILLATORS MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Key market trends
4.1.2. Growth factors and opportunities
4.1.3. Market size and forecast

4.2. MANUAL EXTERNAL DEFIBRILLATOR

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. AUTOMATED EXTERNAL DEFIBRILLATOR (AED)

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast By Type
4.3.4. Market size and forecast By Geography

4.4. WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD)

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

CHAPTER 5. EXTERNAL DEFIBRILLATORS MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast

5.3. PREHOSPITALS

5.3.1. Market size and forecast

5.4. PUBLIC ACCESS MARKETS

5.4.1. Market size and forecast

5.5. ALTERNATIVE CARE MARKET

5.5.1. Market size and forecast

5.6. HOME

5.6.1. Market size and forecast

CHAPTER 6. EXTERNAL DEFIBRILLATORS MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast by Region
6.1.2. Market size and forecast by Product
6.1.3. Market size and forecast by End User

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast by Country
6.2.4. Market size and forecast by Product
6.2.5. Market size and forecast by End User

6.2.5.1. U.S. market size and forecast
6.2.5.2. Canada market size and forecast
6.2.5.3. Mexico market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast by Country
6.3.4. Market size and forecast by Product
6.3.5. Market size and forecast by End User

6.3.5.1. UK market size and forecast
6.3.5.2. Germany market size and forecast
6.3.5.3. France market size and forecast
6.3.5.4. Italy market size and forecast
6.3.5.5. Spain market size and forecast
6.3.5.6. Rest of Europe market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size and forecast by Country
6.4.4. Market size and forecast by Product
6.4.5. Market size and forecast by End User

6.4.5.1. Japan market size and forecast
6.4.5.2. China market size and forecast
6.4.5.3. India market size and forecast
6.4.5.4. Australia market size and forecast
6.4.5.5. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Growth factors and opportunities
6.5.3. Market size and forecast by Country
6.5.4. Market size and forecast by Product
6.5.5. Market size and forecast by End User

6.5.5.1. Brazil market size and forecast
6.5.5.2. Argentina market size and forecast
6.5.5.3. Egypt market size and forecast
6.5.5.4. Israel market size and forecast
6.5.5.5. South Africa market size and forecast
6.5.5.6. Rest of LAMEA market size and forecast

CHAPTER 7. COMPANY PROFILES

7.1. NIHON KOHDEN CORPORATION

7.1.1. Company overview
7.1.2. Operating business segments
7.1.3. Business performance
7.1.4. Key strategic moves and developments

7.2. CARDIAC SCIENCE CORPORATION

7.2.1. Company overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves and developments

7.3. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)

7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Business performance
7.3.4. Key strategic moves and developments

7.4. HEARTSINE TECHNOLOGIES LLC.

7.4.1. Company overview
7.4.2. Operating business segments
7.4.3. Business performance
7.4.4. Key strategic moves and developments

7.5. ZOLL MEDICAL CORPORATION

7.5.1. Company overview
7.5.2. Operating business segments
7.5.3. Business performance
7.5.4. Key strategic moves and developments

7.6. MINDRAY MEDICAL INTERNATIONAL LIMITED

7.6.1. Company overview
7.6.2. Operating business segments
7.6.3. Business performance
7.6.4. Key strategic moves and developments

7.7. DEFIBTECH, LLC

7.7.1. Company overview
7.7.2. Operating business segments
7.7.3. Business performance
7.7.4. Key strategic moves and developments

7.8. PHYSIO-CONTROL, INC.

7.8.1. Company overview
7.8.2. Operating business segments
7.8.3. Business performance
7.8.4. Key strategic moves and developments

7.9. GENERAL ELECTRIC COMPANY (GE HEALTHCARE)

7.9.1. Company overview
7.9.2. Operating business segments
7.9.3. Business performance
7.9.4. Key strategic moves and developments

7.10. SCHILLER AG

7.10.1. Company overview
7.10.2. Operating business segments
7.10.3. Business performance
7.10.4. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Defibtech, Llc
  • GE Healthcare
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Physio-Control, Inc
  • Schiller Ag
  • MORE
External Defibrillators Market report, forecasts that the global market was valued at $4,345 million in 2016 and is expected to garner $7,512 million by 2023, registering a CAGR of 7.8% during the forecast period 2017 - 2023. Automated External defibrillators (AEDs) segment accounted for more than five-sevenths share of the global market in 2016.

External defibrillators are devices used to deliver therapeutic shock to a patients heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The major factors that boost the market growth include technological advancements such as advent of automated external defibrillators (AEDs) for public access places, rise in incidence of sudden cardiac arrest, and growth in awareness toward public access defibrillators worldwide. Moreover, improving healthcare attractiveness is anticipated to boost the sale of home care defibrillators such as wearable external defibrillators and automated external defibrillator (AEDs). The ability of the defibrillator device to diagnose early onset of ventricular tachycardia and ventricular defibrillation is expected to promote their demand. Nevertheless, cost-effectiveness, safety, high accessibility, and clinical value in preliminary treatment of sudden cardiac arrest strengthen the technological advancements in the defibrillators market. However, lack of awareness toward the availability of external defibrillator to prevent sudden cardiac arrest (SCA) and safety concerns related to automated external defibrillators are projected to hamper the market growth.

Automated external defibrillator segment dominated the global market in 2016, in terms of value and volume both, and is expected to maintain this trend throughout the analysis period. This is primarily because of the increase in installations at public places such as schools, work place, airports, sports arenas, government offices, and other public or private places, where large people with high risk of heart attack gather. The growth in demand for AEDs in the developed economies such as North America and Europe further boost the market growth.

Wearable cardioverter defibrillator (WCDs) is poised to grow at the fastest rate during the forecast period owing to the non-invasive nature and increased demand of home healthcare for the treatment of sudden cardiac arrest. Wearable external defibrillator segment is expected to grow at a remarkable CAGR of 11.3% from 2017-2023.

However, Asia-Pacific is projected to be the fastest growing region throughout the analysis period. Japan being the leader in the Asia-Pacific external defibrillator market, where the country contributes solely for the AEDs market share. This is mainly due to the rise in awareness regarding the early prevention of sudden cardiac arrest. Also, improvement in healthcare infrastructures and rise in expenditures in the emerging markets (such as India and China) to overcome the unmet medical needs in these countries boost the market growth. Technological advancements for cost-effective devices in these nations offer a lucrative opportunity for the defibrillator market growth.

Key Findings of External Defibrillators Market:

In 2016, automated external defibrillators (AEDs) led the overall external defibrillator market revenue, and is projected to grow at a CAGR of 7.8% during the forecast period.
The AEDs segment occupied the highest share in 2016, and is expected to grow at a CAGR of 12.8%, in terms of volume.
North America was the leading consumer of external defibrillators in 2016, both in terms of value and volume, followed by Europe.
Japan is expected to lead market in the Asia-Pacific region in 2016, growing at a CAGR 8.9% from 2017-2023.
Key players operating in the market include Nihon Kohden Corporation, Cardiac Science Corporation, Philips Healthcare, HeartSine Technologies LLC., ZOLL Medical Corporation, Mindray Medical International Limited, Defibtech, Llc, Physio-Control, Inc., GE Healthcare, and Schiller Ag.
Note: Product cover images may vary from those shown
5 of 5
  • Nihon Kohden Corporation
  • Cardiac Science Corporation
  • Philips Healthcare
  • HeartSine Technologies LLC
  • ZOLL Medical Corporation
  • Mindray Medical International Limited
  • Defibtech, Llc
  • Physio-Control, Inc
  • GE Healthcare
  • Schiller Ag
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll